Therapeutic window for 5-HT reuptake inhibitors.
W
W
Pitchot
A
A
Gonzalez-Moreno
M
M
Ansseau
D000328:Adult; D005260:Female; D016666:Fluvoxamine / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D014179:Neurotransmitter Uptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D012701:Serotonin / Q000378:metabolism*
D014179:Neurotransmitter Uptake Inhibitors; D012701:Serotonin; D016666:Fluvoxamine